Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation

被引:27
作者
Agrawal, S. [2 ]
Koschmieder, S. [2 ]
Baeumer, N. [2 ]
Reddy, N. G. P. [2 ]
Berdel, W. E. [2 ]
Mueller-Tidow, C. [2 ]
Serve, H. [1 ]
机构
[1] Univ Frankfurt Klinikum, Med Klin 2, D-60590 Frankfurt, Germany
[2] Univ Munster, Dept Med Hematol & Oncol, Munster, Germany
关键词
acute myeloid leukemia; signal transduction; cell cycle regulation; pim kinases; Fms-like tyrosine kinase-3;
D O I
10.1038/sj.leu.2404988
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pim2 is a serine/threonine kinase expressed at high levels in several malignancies including acute leukemia. Pim2 protein is induced by oncogenic Fms-like tyrosine kinase-3 (Flt3)- internal tandem duplications (ITD), but not by Flt3 wild-type receptor (Flt3-Wt) in response to Flt3 ligand (FL). Here we show that Pim2 can complement Flt3-Wt signaling and induce transformation similar to Flt3-ITD in myeloid cells. Our data demonstrate that Pim2 is necessary but not sufficient for Flt3-ITD-induced transformation of 32D cells and primary bone marrow cells as assessed by colony assays. Pim2-induced clonogenic growth of FL-treated 32D-Flt3-Wt cells. Proliferation of 32D-Flt3-Wt cells was significantly enhanced in FL-treated Pim2-overexpressing cells. This increase was associated with enhanced Sphase cell cycle progression. Pim2-overexpressing cells were resistant to apoptosis induced by growth factor deprivation or treatment with tyrosine kinase inhibitor (PKC412). The Flt3 point mutant D835Y, which is not able to support colony growth of myeloid cells, also induced clonogenic growth in the presence of Pim2. In conclusion, Pim2 is an important target of Flt3-ITD-induced transformation, and overexpression of Pim2 together with Flt3-Wt or D835Y receptor mimics Flt3-ITD-mediated transformation. Pim2 complements with Flt3-Wt signaling to induce proliferation by enhancing G(1)/S-phase progression of the cell cycle.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 35 条
[1]   Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL [J].
Adam, M ;
Pogacic, V ;
Bendit, M ;
Chappuis, R ;
Nawijn, MC ;
Duyster, J ;
Fox, CJ ;
Thompson, CB ;
Cools, J ;
Schwaller, J .
CANCER RESEARCH, 2006, 66 (07) :3828-3835
[2]   Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc [J].
Allen, JD ;
Verhoeven, E ;
Domen, J ;
vanderValk, M ;
Berns, A .
ONCOGENE, 1997, 15 (10) :1133-1141
[3]   The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1) -: A novel role for Pim-1 at the G2/M cell cycle checkpoint [J].
Bachmann, M ;
Hennemann, H ;
Xing, PX ;
Hoffmann, I ;
Möröy, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :48319-48328
[4]   Pim-1 associates with protein complexes necessary for mitosis [J].
Bhattacharya, N ;
Wang, ZP ;
Davitt, C ;
McKenzie, IFC ;
Xing, PX ;
Magnuson, NS .
CHROMOSOMA, 2002, 111 (02) :80-95
[5]   Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myelold transformation [J].
Brandts, CH ;
Sargin, B ;
Rode, M ;
Biermann, C ;
Lindtner, B ;
Schwäble, J ;
Buerger, H ;
Müller-Tidow, C ;
Choudhary, C ;
McMahon, M ;
Berdel, WE ;
Serve, H .
CANCER RESEARCH, 2005, 65 (21) :9643-9650
[6]   Pim serine/threonine kinases regulate the stability of Socs-1 protein [J].
Chen, XP ;
Losman, JA ;
Cowan, S ;
Donahue, E ;
Fay, S ;
Vuong, BQ ;
Nawijn, MC ;
Capece, D ;
Cohan, VL ;
Rothman, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2175-2180
[7]   AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations [J].
Choudhary, C ;
Schwäble, J ;
Brandts, C ;
Tickenbrock, L ;
Sargin, B ;
Kindler, T ;
Fischer, T ;
Berdel, WE ;
Müller-Tidow, C ;
Serve, H .
BLOOD, 2005, 106 (01) :265-273
[8]  
DAUTRY F, 1988, J BIOL CHEM, V263, P17615
[9]  
Fenski R, 2000, BRIT J HAEMATOL, V108, P322
[10]   The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor [J].
Fox, CJ ;
Hammerman, PS ;
Cinalli, RM ;
Master, SR ;
Chodosh, LA ;
Thompson, CB .
GENES & DEVELOPMENT, 2003, 17 (15) :1841-1854